Lexicon Pharmaceuticals
LXRX
#6004
Rank
A$1.64 B
Marketcap
A$3.69
Share price
11.35%
Change (1 day)
194.36%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.28. In 2024 the company made an earnings per share (EPS) of A-$0.93 an increase over its 2023 EPS that were of A-$1.16.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-67.42%
2024A-$0.93-20%
2023A-$1.1631.15%
2022A-$0.88-0%
2021A-$0.8810.91%
2020A-$0.80-145.08%
2019A$1.77-206.09%
2018A-$1.67-5.74%
2017A-$1.77-10.95%
2016A-$1.992640%
2015A-$0.07245-96.34%
2014A-$1.98-2.53%
2013A-$2.03-9.09%
2012A-$2.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$26.40-9,689.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$8.01-3,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$61.63-22,484.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.85 3,115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$9.13-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.72 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.09 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.03-836.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$111.15 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA